MINNEAPOLIS, Minnesota — A former executive with Medtronic Inc. and CoreValve Inc. has joined Essex Woodlands Health Ventures to start a medical-devices investment fund.
Dan Lemaitre will lead the new White Pine Medical fund, which has received a financing commitment of “up to” $50 million from Essex Woodlands, according to a statement from the company.
Lemaitre was chief executive of CoreValve, an Irvine, Calif., cardiovascular device firm that was acquired for $700 million by Medtronic last year. Prior to that, Lemaitre was a senior vice president with Medtronic, where he led strategic planning and corporate development and was a member of the company’s executive and operating committees, according to the statement.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“Valuations in the medical device arena are extraordinarily attractive due to a litany of ambiguities, yet the sector provides exceptional growth opportunities for companies that commercialize products that offer better, cost-effective and less invasive treatments,” Lemaitre said.
Essex Woodlands Health Ventures was founded in 1985 and has offices in Palo Alto, Calif.; Houston, New York and London. In that time, the company has raised eight funds and now has nearly $2.5 billion under management.
The firm invests in pharmaceuticals, biotechnology, devices, health services and managed care. Several of its device portfolio companies hail from Minnesota, including ATS Medical and Entellus Medical.
